Cochrane Abstracts
Rosiglitazone for type 2 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Rosiglitazone for Type 2 Diabetes Mellitus." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Cyclosporin_versus_tacrolimus_for_liver_transplanted_patients_Edited__no_change_to_conclusions_. Accessed 07 June 2023.
Rosiglitazone for type 2 diabetes mellitus. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Cyclosporin_versus_tacrolimus_for_liver_transplanted_patients_Edited__no_change_to_conclusions_. Accessed June 7, 2023.
Rosiglitazone for type 2 diabetes mellitus. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Cyclosporin_versus_tacrolimus_for_liver_transplanted_patients_Edited__no_change_to_conclusions_
Rosiglitazone for Type 2 Diabetes Mellitus [Internet]. In: Cochrane Abstracts. [cited 2023 June 07]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Cyclosporin_versus_tacrolimus_for_liver_transplanted_patients_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Rosiglitazone for type 2 diabetes mellitus
ID - 434693
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434693/all/Cyclosporin_versus_tacrolimus_for_liver_transplanted_patients_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -
